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MATERIALS AND METHODS
Experimental animals and sampling
All procedures and protocols used in this study were approved
by the Institutional Animal Care and Use Committee of the
Tokushima University Graduate School. Sprague-Dawley rats
were obtained from Japan SLC Inc. (Shizuoka, Japan). Pregnancy
was determined by the detection ofa vaginal plug. Before removal of
the embryos, pregnant rats were anesthetized by isoflurane with
oxygen gas. Embryos were removed and decapitated on day 16
(E16), and day 18 (E18) of gestation. Embryonic kidneys from E16
and E18, as well as postnatal kidneys from rats at 1 (P1), 7 (P7),
and 20 (P20) days after birth, were harvested. For histology and
immunohistochemistry, parts of kidneys were fixed with 10%
neutral buffered formalin (4, 10).
Antibodies (Abs)
Antibodies (Abs) against Nox1, Nox3, and Nox4 were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Abs for
Nox2, p47phox, and p67phox were kindly provided by Dr. Quinn
at Montana State University (12). A mouse monoclonal anti-
proliferating cell nuclear antigen (PCNA) antibody was purchased
from Calbiochem Merck KGaA (Darmstadt, Germany). Polyclonal
rabbit anti - total -ERK1/2 antibodies and a monoclonal mouse anti -
phospho-ERK1/2 antibody were purchased from Santa Cruz
Biotechnology for western blotting analysis. Polyclonal rabbit anti -
cleaved caspase-3 was purchased from Cell Signaling Technology
(Danvers, MA, USA).
Western blotting
Whole kidneys from E16, E18, P1, P7, and P20 were harvested
and homogenized using fifteen strokes of a motor-driven Teflon
pestle in a tightly fitted glass tube in cell lysis buffer containing
protease inhibitors (Cell Signaling Technology). After incubation
of samples on ice for 15 min, insoluble materials were removed by
centrifugation (10,500 × g, 10 min). The protein content in kidney
lysates was measured by using a BCA protein assay kit (Pierce
Biotechnology, Rockford, IL, USA). Protein samples (30 µg) were
separated by 12.5% sodium dodecyl sulfate polyacrylamide gel
electrophoresis and transferred to nitrocellulose membranes
(Amersham Bioscience, Piscataway, NJ, USA). The membranes
were probed with primary antibodies, then incubated with horse-
radish peroxidase-conjugated secondary antibodies. Immunore-
active proteins were detected with an enhanced chemiluminescence
detection system (Amercham Corp., Arlington Heights, IL, USA).
Bands were quantified by using ImageJ 1.33u (National Institutes of
Health) (13).
Histology and immunohistochemistry
To examine the expression and localization of NADPH oxidase,
paraffin sections (3-µm-thick) were deparaffinized and rehydrated.
Endogenous peroxidase activity was quenched by incubating
sections in 2.0% H2O2/methanol for 30 min. To unmask antigens,
slides were autoclaved at 121 for 10 min in 0.01 M citrate buffer
(pH 6.0). The expressions of NADPH oxidase components were
detected by an immunoperoxidase technique as previous de-
scribed (12). Briefly, the sections were incubated with primary
antibodies against NADPH oxidase (all antibodies diluted to 1 :
100) for 24 h at 4. After washing, the sections were incubated
with biotinylated secondary antibodies, then with avidin-biotin-
peroxidase (ABC Elite ; Vector Laboratories, Burlingame, CA,
USA) ; immunoreaction products were developed by using 3, 3’ -
diaminobenzidine (Dojindo, Kumamoto, Japan). The sections
were then counterstained with Mayer’s hematoxylin (Wako,
Tokyo, Japan), dehydrated, and coverslipped prior to analysis.
Organ Culture
Embryonic day 14 (E14) and E18 metanephroi were explanted
onto 3-μm Nucleopore filters (Corning Costar Corporation,
Cambridge, MA, USA) at the interface between air/5% CO2 atmos-
phere and medium ; they were then cultured at 37 in control
medium comprising RPMI, 5% fetal bovine serum, 2 mM glu-
tamine, 100 U/ml penicillin, and 100 mg/ml streptomycin, in
accordance with previously described conditions with some modifi-
cation (14). To determine the role of ROS produced by NADPH
oxidase in UB branching and nephrogenesis, we incubated the
kidneys with NADPH oxidase inhibitors (diphenyleneiodonium ;
DPI and apocynin) for 48 h. At E14 + 2 days, UB branching was
counted by using FITC-labeled Dolichos biflorus agglutinin (DBA)
lectin, which binds to UB/collecting duct epithelia (15). At E18 + 2
days, nephrogenesis was assessed on PAS-stained sections. In
addition, we examined the number of PCNA-positive cells, as well
as the expression of phosphorylated-ERK1/2 (p-ERK1/2) and
cleaved caspase-3, to assess proliferation, migration, and apoptosis.
In situ superoxide production
In situ production of O2was determined by using whole E14
metanephroi cultured for 2 days, or 30-μm sections of frozen
tissue of E18 metanephroi cultured for 2 days that were incubated
with dihydroethidium (DHE ; 10 μmol/L) in PBS for 30 min at
37 in a humidified chamber that was shielded from light. Upon
reaction with O2, DHE is oxidized to ethidium bromide, which
binds to DNA in the nucleus and fluoresces red. To detect ethidium
bromide, we used a 543-nmHe-Ne laser combined with a 560-nm
long-pass filter. To identify O2-producing cells, we performed
immunofluorescent staining combining the DHE assay (red) with
FITC-labeled (green) anti -DBA-lectin antibody (12, 13).
Statistical analysis
Values are expressed as means standard deviation (SD).
Differences were evaluated with the StatMate 3 software package
(ATMS Co., Ltd., Tokyo, Japan). Comparisons of variables among
groups were performed by using one-way ANOVA and Dunnett’s
test (13). All experiments were repeated at least three times.




Western blotting was performed to examine protein levels of
each NADPH oxidase component during different stages of rat
kidney development. The same amount of protein samples was
applied and separated by electrophoresis to detect each compo-
nent of NADPH oxidase. All components were expressed in embry-
onic and postnatal kidneys (Figure 1a). The protein levels of Nox1,
Nox3, Nox4, and p67 were significantly increased at P7, P20, P1,
and P1 respectively. The levels of Nox2 and p47phox were not
significantly altered in whole kidneys (Figure 1b).
Immunohistochemistry
Immunohistochemistry revealed that Nox1, an NADPH oxidase
component was primarily expressed in UB cells and condensed
mesenchymal cells at E16 and E18 (Figure 2a). At E18 and P1,they
were also detected in immature glomerular endothelial and mesan-
gial cells, and in tubular epithelial cells in nephrogenic zones
(Figure 2b). Expression of Nox1 was weak in the cortex of adult
kidney (P20). In contrast, Nox1 was expressed in renal tubules in
the medulla of adult kidney (P20) (Figure 2c, 2d). The localization
and expression of other NADPH oxidase components (Nox2, Nox3,
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Nox4, p47phox, and p67phox) were comparable to those of Nox1.
These results suggested that the expression of NADPH oxidase
components was spatiotemporally regulated during kidney devel-
opment.
Effect of NADPH oxidase inhibitor on UB branching
Double labeling with FITC-DBA lectin and the DHE assay
showed ROS production in UB epithelia. DPI treatment (1 × 10 - 6 M)
for 2 days suppressed ROS production and reduced the kidney size
and number of ureteric bud branches (71.4%, P0.05) and tips
(66.7%, P0.05) in E14 kidneys (Figure 3). Both ROS production
and NADPH oxidase localization were observed in UB branches
and nephrogenic zones. In addition, organ culture with apocynin
(1 × 10 - 3 M), another NADPH oxidase inhibitor, showed similar
results (data not shown).
Effect of NADPH oxidase inhibitor on nephrogenesis
At E18, inhibition of NADPH oxidase suppressed ROS produc-
tion in nephrogenic zones, as well as nephron formation ; it also
reduced the width of nephrogenic zones (P0.01), but did not
change overall kidney size. Notably, it reduced the number of
PCNA-positive cells and levels of p-ERK1/2, and increased the
Figure1. Expression of NADPH oxidase components, Nox1, Nox2, Nox3, Nox4, p47phox, and p67phox during the development of rat kidneys
(a) Western blotting bands showed the expression level of NADPH oxidase components during renal development (E16, E18, P1, P7, andP20). (b)
Results are shown as meansstandard deviations of at least three independent experiments. Significant differences versus E16 : *p0.05 ; †p0.01.
Figure2. Representative expression and localization of Nox1 in developing kidney
(a) In E16 kidneys, Nox1 expression was detected in ureteric bud and condensed mesenchymal cells, indicated by red arrows.
(b) In E18, Nox1 was expressed in immature mesangial and epithelial cells in the nephrogenic zone.
(c) In P20, Nox1 expression was reduced in mature glomeruli in the cortex of adult kidney.
(d) In P20, Nox1 was expressed in renal tubules in the medulla of adult kidney.
The localization and expression of other NADPH oxidase components (Nox2, Nox3, Nox4, p47phox, and p67phox) were comparable to those of Nox1.
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level of cleaved caspase-3 (Figure 4). Western blotting demon-
strated that inhibition of superoxide production by DPI reduced
levels of p-ERK1/2 and increased levels of cleaved caspase-3 in
organ cultures of both E14 and E18 kidney (P0.01) (Figure 5).
DISCUSSION
Metanephric kidney develops through reciprocal inductive
interactions between the UB and metanephric mesenchyme (16).
Induced by mesenchymal signals, the UB elongates and under-
goes repetitive branching to form the renal collecting system
(branching morphogenesis). In turn, UB tips stimulate the mesen-
chyme to differentiate into nephron epithelia ; the progression
occurs from renal vesicles to comma-shaped bodies, then to S-
shaped bodies, and finally to mature nephron consisting of the
proximal tubule, loop of Henle, and distal tubule (nephrogenesis).
The two representative morphogenetic events are tightly controlled
by multiple gene regulatory networks, as well as signaling path-
ways (16-18). Abnormal UB branching results in a spectrum of
CAKUT, the major cause of end-stage kidney disease in children
(16). Maternal malnutrition often induces the development of
intrauterine growth restriction (IUGR) accompanied by low nephron
number in the fetus, which is ultimately associated with an in-
creased risk of chronic kidney disease in adulthood (19).
In this study, we showed the crucial role of ROS, generated by
NADPH oxidase, in the process of branching morphogenesis, as
well as nephrogenesis in the kidney. Notably, the expression of
ROS-producing NADPH oxidase components is spatiotemporally
altered according to the stages of kidney development. In general,
these expression levels correspond with the level of ROS produc-
tion within the kidney in a regional and cell -specific manner (20).
NADPH oxidase-derived ROS seems to affect the cell proliferation,
migration, and apoptosis involved in UB branching and nephro-
genesis via activation of ERK1/2 and expression of caspase-3.
Thus, NADPH oxidase expression appears to be high in developing
Figure3. The effect of Nox inhibitor (diphenyleneiodonium ; DPI) on ureteric bud (UB) branching
Whole kidneys were simultaneously stained with FITC-DBA lectin (green ; a and d) and by DHE assay (red ; b and e) after organ culture of E14
kidneys for 2 days. FITC-DBA lectin (green) and DHE assay (red) demonstrated UB branching and superoxide production, respectively. The
merged images are shown (c and f). The representative organ culture experiments were performed by incubation for 2 days with 1 × 10 - 5 M of DPI, the
Nox inhibitor. The representative images were shown as control (a,b,c) and the kidneys treated by 1 × 10 - 5 M of DPI (d,e,f).
Superoxide production was detected in UB and suppressed by DPI treatment. UB branching in E14 organ culture was reduced in a dose-dependent
manner in the presence of DPI (g). Results are shown as meansstandard deviations of at least three independent experiments. Significant
differences versus control (C) : *p0.05 ; †p0.01. Kidney growth was also inhibited by the addition of apocynin.
Figure4. The effect of Nox inhibitor (diphenyleneiodonium ; DPI) on nephrogenesis
Histochemical (PAS ; b and i) and immunohistochemical assessment (PCNA ; d and k, p -ERK ; e and l, and cleaved caspase-3 ; f and m) and the
detection of superoxide production by DHE assay (c and j) were performed after organ culture of E18 kidneys for 2 days.
DPI treatment (1 × 10 - 5 M) impeded ROS production and reduced nephron formation in the nephrogenic zone, as well as the width of the
nephrogenic zone. Differences in kidney size were not observed (a, g, h). DPI treatment also reduced the number of PCNA-positive cells and the
levels of p -ERK1/2, while increasing the level of cleaved caspase-3.
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kidney while low in developed kidney.
Our observations in this study are partially in agreement with
the work by Zhang et al., which revealed that hyperglycemic
intrauterine conditions increase UB branching morphogenesis by
enhancing ROS generation through the activation of NADPH
oxidase and mitochondrial oxidase (11). It was recently discovered
that NADPH oxidase-dependent ROS are not limited to roles in
cellular and tissue damage, and that they contribute to physi-
ological processes of organ development in a carefully regulated
manner (2). There is increasing evidence to indicate that adequate
NADPH oxidase-mediated ROS production is required for neuro-
genesis and cardiogenesis, suggesting that physiological levels of
NADPH oxidase-dependent ROS may be necessary for renal
developmental, such as UB branching and nephrogenesis (7, 8).
Consideration should be given to the close relationship between
activation of the renal renin angiotensin system (RAS) and kidney
development during the fetal period (16). Genetic inactivation of
RAS constituents such as AGT, ACE, prorenin receptor (PRR),
combined AT1A/AT1BR, and AT2R in murine RAS induces abnor-
mal renal phenotypes, such as CAKUT (e.g., hypodysplasia of the
renal papilla, hydronephrosis, or renal tubular dysgenesis (RTD)),
or immature glomerular filtration (16). Of note, the use of RAS
inhibitors, such as angiotensin-converting enzyme inhibitors
(ACEIs) or angiotensin receptor blockers (ARBs), is prohibited in
pregnant women ; when these agents have mistakenly been used,
the occurrence of renal dysplasia, including RTD (as a kidney
phenotype of ACEI/ARB fetopathy), has been reported (21). In
consideration of the extensive data that show Ang II can serve as a
powerful inducer for UB branching, in combination with renal
NADPH oxidase-derived ROS (22), the potential role of Ang II in
kidney development may be partially mediated through the action of
NADPH oxidase-derived ROS in the developing kidney.
Involvement of ROS-mediated signal pathways in kidney devel-
opment remains unclear. The present study indicates that ERK1/2
phosphorylation, as well as cleaved caspase-3 expression, which
are altered by ROS production within kidney, at least partly con-
tribute to two key morphologic events in renal development. Large-
scale proliferation and apoptosis events have been observed in
these cells (18). Many reports have implicated MAP kinases, such
as ERK1/2 and p38, in cell behaviors necessary for branching
morphogenesis and nephrogenesis in kidney (23, 24). Additionally,
high glucose- increased UB branching morphogenesis has been
shown to occur, at least in part, via ROS generation, activation of
Akt signaling, and upregulation of Pax-2 gene expression (11).
Further investigations are needed to fully elucidate the roles of
renal NADPH oxidase expression, ROS, and relevant signaling
pathways in fine-tuned mechanisms of renal morphogenesis during
the course of renal development.
In conclusion, the present study indicated that reduced ROS
production impedes UB branching and nephrogenesis in the
developing kidney. Considering the two critical findings of the
involvement of RAS in renal development and Ang II - induced ROS
production via NAPDH oxidases, appropriate modulation of ROS
production for IUGR and premature babies might provide a thera-
peutic strategy to increase nephron number in these babies and
prevent the development of CAKUT.
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Figure 5. The effect of Nox inhibitor (diphenyleneiodonium ; DPI) on ureteric bud (UB) branching and nephrogenesis by organ culture of
developing kidneys
Western blotting demonstrated that inhibition of superoxide production by the treatment of DPI (1 × 10 - 5 M) reduced levels of p -ERK1/2, and
increased levels of cleaved caspase-3 in developing kidneys after organ culture of both E14 and E18 kidneys for 2 days, respectively (a).
Representative western blotting is shown (a). Bands indicating levels of p -ERK1/2 and cleaved caspase-3 were quantified by ImageJ 1.33u (National
Institutes of Health) and are shown as b and c, respectively. The results are shown as meansstandard deviations of at least three independent
experiments. Significant differences of addition of DPI (10 - 5) versus control (cont) : *p0.01.
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